Using NPC as a disease model, a comprehensive analysis was undertaken to examine the clinical significance of EZH2 expression, identification of the cellular processes regulated by EZH2, and the mechanisms of its deregulated expression. This evidence concerns the gene EZH2 and nasopharyngeal carcinoma.